The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Cancer Therapy and Testing market size was valued at USD 720270 million in 2022 and is forecast to a readjusted size of USD 1646460 million by 2029 with a CAGR of 12.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The cancer therapy and testing market has been witnessing significant growth over the years and is expected to continue expanding in the future. Several factors contribute to this market growth, including the increasing incidence of cancer globally, advancements in diagnostic technologies, personalized medicine approaches, and a growing emphasis on early detection and targeted therapies.
Cancer Therapy and Testing
This report is a detailed and comprehensive analysis for global Cancer Therapy and Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
- Global Cancer Therapy and Testing market size and forecasts, in consumption value ($ Million), 2018-2029
- Global Cancer Therapy and Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
- Global Cancer Therapy and Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
- Global Cancer Therapy and Testing market shares of main players, in revenue ($ Million), 2018-2023.
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Cancer Therapy and Testing
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace.
This report profiles key players in the global Cancer Therapy and Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Invitae, Foundation Medicine, Guardant Health, Illumina and Sysmex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cancer Therapy and Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cancer Detection
- Cancer Treatment
Market segment by Application
- Lung Cancer
- Rectal Cancer
- Breast Cancer
- Other
Market segment by players, this report covers
- Invitae
- Foundation Medicine
- Guardant Health
- Illumina
- Sysmex
- Abingdon Health
- Sophia
- NanoEntek
- BGI
- Diagnosis
- Exact Sciences
- AstraZeneca
- Bayer AG
- Johnson & Johnson
- Pfizer Inc.
Market segment by regions, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Therapy and Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Therapy and Testing, with revenue, gross margin and global market share of Cancer Therapy and Testing from 2018 to 2023.
Chapter 3, the Cancer Therapy and Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cancer Therapy and Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Therapy and Testing.
Chapter 13, to describe Cancer Therapy and Testing research findings and conclusion.
Index
1 Market Overview
1.1 Product Overview and Scope of Cancer Therapy and Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cancer Therapy and Testing by Type
1.3.1 Overview: Global Cancer Therapy and Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cancer Therapy and Testing Consumption Value Market Share by Type in 2022
1.3.3 Cancer Detection
1.3.4 Cancer Treatment
1.4 Global Cancer Therapy and Testing Market by Application
1.4.1 Overview: Global Cancer Therapy and Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Lung Cancer
1.4.3 Rectal Cancer
1.4.4 Breast Cancer
1.4.5 Other
1.5 Global Cancer Therapy and Testing Market Size & Forecast
1.6 Global Cancer Therapy and Testing Market Size and Forecast by Region
1.6.1 Global Cancer Therapy and Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cancer Therapy and Testing Market Size by Region, (2018-2029)
1.6.3 North America Cancer Therapy and Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Cancer Therapy and Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cancer Therapy and Testing Market Size and Prospect (2018-2029)
1.6.6 South America Cancer Therapy and Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cancer Therapy and Testing Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Invitae
2.1.1 Invitae Details
2.1.2 Invitae Major Business
2.1.3 Invitae Cancer Therapy and Testing Product and Solutions
2.1.4 Invitae Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Invitae Recent Developments and Future Plans
2.2 Foundation Medicine
2.2.1 Foundation Medicine Details
2.2.2 Foundation Medicine Major Business
2.2.3 Foundation Medicine Cancer Therapy and Testing Product and Solutions
2.2.4 Foundation Medicine Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Foundation Medicine Recent Developments and Future Plans
2.3 Guardant Health
2.3.1 Guardant Health Details
2.3.2 Guardant Health Major Business
2.3.3 Guardant Health Cancer Therapy and Testing Product and Solutions
2.3.4 Guardant Health Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Guardant Health Recent Developments and Future Plans
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business
2.4.3 Illumina Cancer Therapy and Testing Product and Solutions
2.4.4 Illumina Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Illumina Recent Developments and Future Plans
2.5 Sysmex
2.5.1 Sysmex Details
2.5.2 Sysmex Major Business
2.5.3 Sysmex Cancer Therapy and Testing Product and Solutions
2.5.4 Sysmex Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sysmex Recent Developments and Future Plans
2.6 Abingdon Health
2.6.1 Abingdon Health Details
2.6.2 Abingdon Health Major Business
2.6.3 Abingdon Health Cancer Therapy and Testing Product and Solutions
2.6.4 Abingdon Health Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abingdon Health Recent Developments and Future Plans
2.7 Sophia
2.7.1 Sophia Details
2.7.2 Sophia Major Business
2.7.3 Sophia Cancer Therapy and Testing Product and Solutions
2.7.4 Sophia Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sophia Recent Developments and Future Plans
2.8 NanoEntek
2.8.1 NanoEntek Details
2.8.2 NanoEntek Major Business
2.8.3 NanoEntek Cancer Therapy and Testing Product and Solutions
2.8.4 NanoEntek Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 NanoEntek Recent Developments and Future Plans
2.9 BGI
2.9.1 BGI Details
2.9.2 BGI Major Business
2.9.3 BGI Cancer Therapy and Testing Product and Solutions
2.9.4 BGI Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BGI Recent Developments and Future Plans
2.10 Diagnosis
2.10.1 Diagnosis Details
2.10.2 Diagnosis Major Business
2.10.3 Diagnosis Cancer Therapy and Testing Product and Solutions
2.10.4 Diagnosis Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Diagnosis Recent Developments and Future Plans
2.11 Exact Sciences
2.11.1 Exact Sciences Details
2.11.2 Exact Sciences Major Business
2.11.3 Exact Sciences Cancer Therapy and Testing Product and Solutions
2.11.4 Exact Sciences Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Exact Sciences Recent Developments and Future Plans
2.12 AstraZeneca
2.12.1 AstraZeneca Details
2.12.2 AstraZeneca Major Business
2.12.3 AstraZeneca Cancer Therapy and Testing Product and Solutions
2.12.4 AstraZeneca Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 AstraZeneca Recent Developments and Future Plans
2.13 Bayer AG
2.13.1 Bayer AG Details
2.13.2 Bayer AG Major Business
2.13.3 Bayer AG Cancer Therapy and Testing Product and Solutions
2.13.4 Bayer AG Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bayer AG Recent Developments and Future Plans
2.14 Johnson & Johnson
2.14.1 Johnson & Johnson Details
2.14.2 Johnson & Johnson Major Business
2.14.3 Johnson & Johnson Cancer Therapy and Testing Product and Solutions
2.14.4 Johnson & Johnson Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Johnson & Johnson Recent Developments and Future Plans
2.15 Pfizer Inc.
2.15.1 Pfizer Inc. Details
2.15.2 Pfizer Inc. Major Business
2.15.3 Pfizer Inc. Cancer Therapy and Testing Product and Solutions
2.15.4 Pfizer Inc. Cancer Therapy and Testing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Pfizer Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Therapy and Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cancer Therapy and Testing by Company Revenue
3.2.2 Top 3 Cancer Therapy and Testing Players Market Share in 2022
3.2.3 Top 6 Cancer Therapy and Testing Players Market Share in 2022
3.3 Cancer Therapy and Testing Market: Overall Company Footprint Analysis
3.3.1 Cancer Therapy and Testing Market: Region Footprint
3.3.2 Cancer Therapy and Testing Market: Company Product Type Footprint
3.3.3 Cancer Therapy and Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Cancer Therapy and Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cancer Therapy and Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Cancer Therapy and Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Cancer Therapy and Testing Market Forecast by Application (2024-2029)
6 North America
6.1 North America Cancer Therapy and Testing Consumption Value by Type (2018-2029)
6.2 North America Cancer Therapy and Testing Consumption Value by Application (2018-2029)
6.3 North America Cancer Therapy and Testing Market Size by Country
6.3.1 North America Cancer Therapy and Testing Consumption Value by Country (2018-2029)
6.3.2 United States Cancer Therapy and Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Cancer Therapy and Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Cancer Therapy and Testing Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Cancer Therapy and Testing Consumption Value by Type (2018-2029)
7.2 Europe Cancer Therapy and Testing Consumption Value by Application (2018-2029)
7.3 Europe Cancer Therapy and Testing Market Size by Country
7.3.1 Europe Cancer Therapy and Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Cancer Therapy and Testing Market Size and Forecast (2018-2029)
7.3.3 France Cancer Therapy and Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cancer Therapy and Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Cancer Therapy and Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Cancer Therapy and Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapy and Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cancer Therapy and Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cancer Therapy and Testing Market Size by Region
8.3.1 Asia-Pacific Cancer Therapy and Testing Consumption Value by Region (2018-2029)
8.3.2 China Cancer Therapy and Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Cancer Therapy and Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Cancer Therapy and Testing Market Size and Forecast (2018-2029)
8.3.5 India Cancer Therapy and Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cancer Therapy and Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Cancer Therapy and Testing Market Size and Forecast (2018-2029)
9 South America
9.1 South America Cancer Therapy and Testing Consumption Value by Type (2018-2029)
9.2 South America Cancer Therapy and Testing Consumption Value by Application (2018-2029)
9.3 South America Cancer Therapy and Testing Market Size by Country
9.3.1 South America Cancer Therapy and Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Cancer Therapy and Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Cancer Therapy and Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapy and Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cancer Therapy and Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cancer Therapy and Testing Market Size by Country
10.3.1 Middle East & Africa Cancer Therapy and Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Cancer Therapy and Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cancer Therapy and Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Cancer Therapy and Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Cancer Therapy and Testing Market Drivers
11.2 Cancer Therapy and Testing Market Restraints
11.3 Cancer Therapy and Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Cancer Therapy and Testing Industry Chain
12.2 Cancer Therapy and Testing Upstream Analysis
12.3 Cancer Therapy and Testing Midstream Analysis
12.4 Cancer Therapy and Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
